For example, in pancreatic cancer cells, oncogenic KRAS increases the flux of glucose carbon through the non-oxidative PPP to favor nucleotide biosynthesis, without altering flux of glucose carbon to the oxidative PPP (ox-PPP). The gene discussed is KRAS; the disease is familial pancreatic carcinoma.